Brogan Inc.
pic-home
Decrease TextIncrease TextRestore Default
Brogan Inc.
Corporate

Product Development & Pricing

Careful planning is essenstial for a successful product launch. To make sensitive decisions during this important stage, access to appropriate and comprehensive economic analyses is crucial.

Through the principles of pharmacoeconomic and decision analysis, we can provide expected market valuations before you spend valuable resources to launch your new product in Canada. We can determine the optimal range for your pricing strategy to help you:

•  Maximize the expected revenue potential of your new product
•  Reduce the likelihood of delays in your new drug's formulary listings
•  Avoid losses of potential revenue due to formulary listing delays or under-pricing

This could include the design and preparation of economic studies which demonstrate the value of the product and provide evidence of the need for the new product in terms of costs of the illness treated.

For more information, please contact our Health Economics department at 613.599.0711.

Back to Top  

Sub Menu
Overview
Price Regulation Consulting
Market Research
Health Economics
Product Development & Pricing
Burden of Illness
Cost Effectiveness Analysis
Finantial Impact Analysis
Outcomes Research
Drug Utilization Research
Market Access
Sales Management
BI & IT Consulting
Drug Plan Data
Login
Corporate
Expertise
Products
Seminars
Publications
News
Careers



Subscribe to our mailing list:

Subscription Form

Copyright